Company: MVIS
Filing Date: 2025-03-26
Form Type: 10-K
Source: 0001641172-25-000783
Chunk: 110

Company: MICROVISION, INC.
Filing Date: 2025-03-26
Form: 10-K
Item: Item 1B
Chunk 110
---
 product sales, and licensing activity payments are currently made
in U.S. dollars or Euros. Changes in the relative value of the U.S. dollar to the Euro and other currencies may affect revenue and other
operating results as expressed in U.S. dollars. In addition, our international subsidiary financial statements are denominated in Euros.
As such, the consolidated financial statements will continue to remain subject to the impact of foreign currency translation as our international
operations continue to expand. In the future, we may enter into foreign currency hedges to offset material exposure to currency fluctuations
when we can adequately determine the timing and amounts of the exposure.

30

ITEM
8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

INDEX
TO CONSOLIDATED FINANCIAL STATEMENTS

    Page
  
    Report of Independent Registered Public Accounting Firm (Moss Adams LLP, Seattle, Washington, PCAOB ID:659)
     
    32

    Consolidated Balance Sheets as of December 31, 2024 and 2023
     
    34

    Consolidated Statements of Operations for the years ended December 31, 2024, 2023 and 2022
     
    35

    Consolidated Statements of Comprehensive Loss for the years ended December 31, 2024, 2023 and 2022
     
    36

    Consolidated Statements of Shareholders’ Equity for the years ended December 31, 2024, 2023 and 2022
     
    37

    Consolidated Statements of Cash Flows for the years ended December 31, 2024, 2023 and 2022
     
    38

    Notes to Consolidated Financial Statements

    39

31

Report
of Independent Registered Public Accounting Firm

To
the Shareholders and the Board of Directors of

MicroVision,
Inc.

Opinion
on the Financial Statements

We
have audited the accompanying consolidated balance sheets of MicroVision, Inc. (the “Company”) as of December 31, 2024
and 2023, the related consolidated statements of operations, comprehensive loss, stockholders’ equity and cash flows for each
of the three years in the period ended December 31, 2024, and the related notes and schedules (collectively referred to as the
“consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all
material respects, the consolidated financial position of